Fred Hutch cancer metabolism expert Dr. Lucas Sullivan discovered that feeding NRF2-mutated tumors too much of a nutrient they crave makes them vulnerable to slower growth and cell death, a ...

Small cell lung cancer, or SCLC, is fraught with challenges. Patients are often diagnosed late so outcomes are poor; therapeutic advances have stalled due to lackluster funding and the disease, ...

Michael Haffner, MD, PhD, and Kevin Cheung, MD, have recently been awarded multi-year research grants from the V Foundation ...

Fred Hutch Esophageal Cancer Specialty Clinic Our esophageal cancer specialists work closely with you, your family and each other to get you back to health. At Fred Hutch, we provide all standard ...

Clinical Laboratory Improvement Amendments, or CLIA, are a high bar as set by the US Government under Clinical Laboratory Improvement Amendment 42 CFR 493.1253 to obtain and maintain quality ...

As wildfire smoke continues to seep into our skies, public health researchers at Seattle's Fred Hutch Cancer Center are sharing tips and tools they hope will help people in the Pacific Northwest (and ...

Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...

The immune system doesn't respond the same way in everyone. Vaccines train it, but some people's bodies mount a much stronger antibody response than others. Researchers have long suspected this ...

A Multidisciplinary Approach to Reducing the Burden of Infectious Disease The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science.

At Fred Hutch Cancer Center, our team of experts cares for people with lung cancer every day. Your Fred Hutch pulmonary (lung) experts specialize in finding out the stage and specific features of your ...